SUTUREGARD^® MEDICAL INC. Blog

Dr. Windy Cole and Alex McKanna have released The Use of a Novel Suture Retention Device to Prevent SWD case report, where the HEMIGARD™ ARS device was used for skin closure and prevent dehiscence. The addition of the HEMIGARD™ constructs to the post-surgical skin closure on the foot allowed for the transfer of tension away from the vulnerable incision site, thus preventing dehiscence.

The Wound Care Learning Networks released a case study focusing on using a novel adhesive suture retention device in lower leg excisional wound closure, with specific use of the HEMIGARD™. The SUTUREGARD® ISR Retention Suture Device and the HEMIGARD™ Adhesive Retention Suture Device allow surgeons to initiate approximation of high-tension surgical wounds with suture without damaging the skin.

JAAD Case Reports recently published, “Use of a novel adhesive suture retention wound closure device to prevent follow-up visits during the COVID-19 pandemic”; a case study demonstrating patient self-removal of sutures after wound closure repair.

SUTUREGARD® Medical has formed a non-exclusive distribution partnership with Federated Healthcare Supply to expand market reach of the HEMIGARD® ARS device and the SUTUREGARD® ISR device which are patented wound closure technologies that simplify complex and challenging wound closures.

SUTUREGARD® is pleased to announce CEO, Dan Ladizinsky, MD, will be presenting for the second time at the American Society of Plastic Surgery Annual Meeting, March 12-14, 2020. Ladizinsky is eager to return with the SUTUREGARD® IRS Retention Suture Device and introduce the HEMIGARD™ Device!

Newly published research in the Journal of Clinical Biomechanics supports using novel devices, such as the SUTUREGARD® ISR Retention Suture Device and the HEMIGARD™ Adhesive Retention Suture Device, to initiate approximation of high-tension surgical wounds. Learn more about Suturegard devices!

SUTUREGARD® Medical will be presenting at the American Society for Mohs Surgery (ASMS) Closure Course in Phoenix, AZ the weekend of January 25th-26th, 2020.

SUTUREGARD® Medical, Inc is excited to announce that CEO Dan Ladizinsky, MD, will be presenting SUTUREGARD® Medical at Arab Health. Arab Health, which runs January 27 to 30 in Dubai, brings in over 4,250 companies to showcase all the latest innovations in healthcare.

The official collaboration between Operation Smile & SUTUREGARD® Medical Inc. Operation Smile is the most prestigious and charitable global plastic surgery organization worldwide, dedicated to improving surgical care of underprivileged peoples, with an emphasis on cleft lip and palate repair.

SUTUREGARD® Medical, Inc is pleased to announce that it will be presenting at the MEDICA International Trade Fair. The fair, which runs from 18 to 21 November in Düsseldorf, Germany, will present a platform for more than 5,000 exhibitors to display innovative products and ideas. It is a vital opportunity for the company to showcase the SUTUREGARD® ISR Retention Suture Device, a patented technology that aids in surgical closure of high-tension wounds through rapid tissue expansion.